The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Biochemical recurrence (BCR) surrogacy for clinical outcomes after radiotherapy for adenocarcinoma of the prostate (BCRSCRAP): A meta-analysis from MARCAP Consortium.
 
Soumyajit Roy
No Relationships to Disclose
 
Tahmineh Romero
No Relationships to Disclose
 
Allison Steigler
No Relationships to Disclose
 
James William Denham
No Relationships to Disclose
 
David John Joseph
No Relationships to Disclose
 
Jeff M. Michalski
Stock and Other Ownership Interests - ViewRay (I)
Consulting or Advisory Role - Blue Earth Diagnostics; Boston Scientific; Merck Sharp & Dohme; Mevion Medical Systems
Research Funding - Merck Sharp & Dohme (Inst)
Travel, Accommodations, Expenses - Boston Scientific; Merck Sharp & Dohme
 
Felix Y Feng
Stock and Other Ownership Interests - Artera
Consulting or Advisory Role - Artera; Astellas Pharma; Bayer; BlueStar Genomics; Bristol Myers Squibb; Bristol Myers Squibb (BMS); Exact Sciences; Foundation Medicine; Janssen Biotech; Myovant Sciences; Novartis; Roivant; SerImmune; Tempus; Varian Medical Systems
Research Funding - Zenith Epigenetics
 
Michel Bolla
No Relationships to Disclose
 
Theo M. de Reijke
No Relationships to Disclose
 
Philippe Maingon
Honoraria - Ipsen
Consulting or Advisory Role - AstraZeneca; BMS France
Speakers' Bureau - Varian Medical Systems
 
Matthew R. Sydes
Honoraria - Janssen; Janssen; Lilly; Sanofi
Research Funding - Astellas Pharma; Clovis Oncology; Janssen-Cilag; Novartis; Pfizer; Sanofi
 
David P. Dearnaley
Consulting or Advisory Role - Janssen Oncology
Patents, Royalties, Other Intellectual Property - Abiraterone acetate was developed at The Institute of Cancer Research, which therefore has a commercial interest in the development of this agent. Professor Dearnaley is on the Institute’s Rewards to Inventors list for abiraterone acetate. (Inst); Patent issued EP1933709B1 (location and stabilisation device)
 
Luca Incrocci
Honoraria - Varian Medical Systems
Research Funding - Varian Medical Systems (Inst)
 
Wilma Heemsbergen
No Relationships to Disclose
 
Abdenour Nabid
No Relationships to Disclose
 
Luis Souhami
No Relationships to Disclose
 
Almudena Zapatero
Consulting or Advisory Role - Bayer
Speakers' Bureau - Astellas Pharma; Janssen
Research Funding - AstraZeneca
Travel, Accommodations, Expenses - Ipsen
 
Yilun Sun
No Relationships to Disclose
 
Daniel Eidelberg Spratt
Honoraria - Varian Medical Systems
Consulting or Advisory Role - AstraZeneca; Bayer; Blue Earth Diagnostics; Boston Scientific; Janssen Oncology; Varian Medical Systems
Research Funding - Janssen (Inst)
 
Amar Upadhyaya Kishan
Stock and Other Ownership Interests - ViewRay
Honoraria - Varian Medical Systems; ViewRay; ViewRay
Consulting or Advisory Role - Boston Scientific; Janssen
Research Funding - Janssen Oncology (Inst); Point Biopharma (Inst); ViewRay; ViewRay